Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of congenital haemophilia A or B with inhibitors development against FVIII or FIX, respectively~Exclusion Criteria:~* Prophylactic administration of any haemostatic drug within 3 last months prior to entering the trial.

- Gender: MALE
- Minimum Age: 2 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).